[MOL] Re: Stem Cell Biology [01813] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Re: Stem Cell Biology





YAMAMOTO T, Eckes B, Mauch C, Hartmann K, Krieg T.
> Monocyte chemoattractant protein-1 enhances gene expression and synthesis
> of matrix metalloproteinase-1 in human fibroblasts by an
> autocrine IL-1 alpha loop.
> J Immunol 2000;164:6174-9.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10843667&aid=B120231&dopt=r&s=stc
>
> VARAS A, Jimenez E, Sacedon R, et al.
> Analysis of the human neonatal thymus: evidence for a transient thymic
involution.
> J Immunol 2000;164:6260-7.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10843679&aid=B120231&dopt=r&s=stc
>
> HOFFMANN KF, Cheever AW, Wynn TA.
> IL-10 and the dangers of immune polarization: excessive type 1 and type
> 2 cytokine responses induce distinct forms of lethal
> immunopathology in murine schistosomiasis.
> J Immunol 2000;164:6406-16.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10843696&aid=B120231&dopt=r&s=stc
>
> BONNET MC, Weil R, Dam E, Hovanessian AG, Meurs EF.
> PKR stimulates NF-kappaB irrespective of its kinase function by
interacting
> with the IkappaB kinase complex.
> Mol Cell Biol 2000;20:4532-42.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10848580&aid=B120231&dopt=r&s=stc
>
> WANG X, McGowan CH, Zhao M, et al.
> Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell
> cycle arrest.
> Mol Cell Biol 2000;20:4543-52.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10848581&aid=B120231&dopt=r&s=stc
>
> DRONKERT ML, de Wit J, Boeve M, et al.
> Disruption of mouse SNM1 causes increased sensitivity to the DNA
interstrand
> cross-linking agent mitomycin C.
> Mol Cell Biol 2000;20:4553-61.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10848582&aid=B120231&dopt=r&s=stc
>
> PAWLAK MR, Scherer CA, Chen J, Roshon MJ, Ruley HE.
> Arginine N-methyltransferase 1 is required for early postimplantation
mouse
> development, but cells deficient in the enzyme are
> viable.
> Mol Cell Biol 2000;20:4859-69.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10848611&aid=B120231&dopt=r&s=stc
>
> VELA-OJEDA J, Tripp-Villanueva F, Montiel-Cervantes L, et al.
> Prospective randomized clinical trial comparing high-dose ifosfamide +
GM-CSF
> vs high-dose cyclophosphamide + GM-CSF for blood
> progenitor cell mobilization.
> Bone Marrow Transplant 2000;25:1141-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10849526&aid=B120231&dopt=r&s=stc
>
> YU J, Leisenring W, Fritschle W, et al.
> Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500
> predicts final CD34+ cell yield in the apheresis collection.
> Bone Marrow Transplant 2000;25:1157-64.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10849528&aid=B120231&dopt=r&s=stc


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------